Published in Urology on May 01, 2006
Diagnostic Challenges in IC (and Male CPPS) | NCT00672087
Linkage Analysis in Interstitial Cystitis (IC) | NCT00675298
Development of an evidence-based cognitive behavioral treatment program for men with chronic prostatitis/chronic pelvic pain syndrome. World J Urol (2008) 1.17
Adrenocortical hormone abnormalities in men with chronic prostatitis/chronic pelvic pain syndrome. Urology (2008) 1.09
Genetics and phenotyping of urological chronic pelvic pain syndrome. J Urol (2009) 1.03
Management of men diagnosed with chronic prostatitis/chronic pelvic pain syndrome who have failed traditional management. Rev Urol (2007) 0.90
New treatments for chronic prostatitis/chronic pelvic pain syndrome. Nat Rev Urol (2010) 0.87
Treatment of chronic prostatitis/chronic pelvic pain syndrome. Int J Antimicrob Agents (2007) 0.85
Cholesterol and benign prostate disease. Differentiation (2011) 0.85
Alpha-blockers for the treatment of prostatitis-like syndromes. Rev Urol (2006) 0.76
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics (2000) 19.26
The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med (1997) 19.14
Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. JAMA (2001) 6.24
NIH consensus definition and classification of prostatitis. JAMA (1999) 5.35
The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V) Arch Intern Med (1993) 5.08
Management of fibromyalgia syndrome. JAMA (2004) 4.47
How common is prostatitis? A national survey of physician visits. J Urol (1998) 2.90
Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med (2004) 2.82
Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial. J Urol (2003) 2.37
Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. Ann Intern Med (2000) 2.27
A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J Urol (2003) 1.90
Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network. J Gen Intern Med (2001) 1.64
Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network. Urology (1999) 1.57
Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology (1999) 1.53
Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome. Urology (2004) 1.49
Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. J Urol (2004) 1.44
Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology (2003) 1.44
Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study. Urology (2003) 1.43
Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome. Urology (2002) 1.21
Overview summary statement. Diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Urology (2002) 0.96
Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study. J Urol (2005) 0.93
Role of mepartricin in category III chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized prospective placebo-controlled trial. Urology (2004) 0.90
The complex world of prescribing behavior. JAMA (2004) 0.87
Few patients with "chronic prostatitis" have significant bladder outlet obstruction. Urology (1998) 0.83
[Efficacy and safety of intraprostatic injection of chuanshentong for chronic abacterial prostatitis/chronic pelvic pain syndrome]. Zhonghua Nan Ke Xue (2004) 0.78
[Alpha-blockers and bioflavonoids in men with chronic nonbacterial prostatitis (NIH-IIIa): a prospective, placebo-controlled trial]. Zhonghua Liu Xing Bing Xue Za Zhi (2004) 0.78
A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med (2006) 21.56
Depression and pain comorbidity: a literature review. Arch Intern Med (2003) 11.34
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med (2003) 11.25
Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? Ann Intern Med (2006) 5.28
Effect of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized controlled trial. JAMA (2003) 5.08
Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol (2011) 5.01
Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care (2004) 4.92
Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9). J Affect Disord (2004) 4.66
Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. J Affect Disord (2004) 4.64
Meta-analysis: outcomes in patients with suspected pulmonary embolism managed with computed tomographic pulmonary angiography. Ann Intern Med (2004) 3.97
Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res (2005) 3.93
Meta-analysis: computed tomographic colonography. Ann Intern Med (2005) 3.66
Common comorbidity scales were similar in their ability to predict health care costs and mortality. J Clin Epidemiol (2004) 3.61
Using the Patient Health Questionnaire-9 to measure depression among racially and ethnically diverse primary care patients. J Gen Intern Med (2006) 3.50
Long term outcomes from the IMPACT randomised trial for depressed elderly patients in primary care. BMJ (2006) 3.47
Care management of poststroke depression: a randomized, controlled trial. Stroke (2007) 3.26
Re-engineering systems for the treatment of depression in primary care: cluster randomised controlled trial. BMJ (2004) 3.23
Treatment of depression improves physical functioning in older adults. J Am Geriatr Soc (2005) 3.11
The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry (2007) 2.98
The association of depression and anxiety with obesity and unhealthy behaviors among community-dwelling US adults. Gen Hosp Psychiatry (2008) 2.92
Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. J Clin Invest (2005) 2.89
Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size. Eur Urol (2008) 2.84
Somatoform disorders: time for a new approach in DSM-V. Am J Psychiatry (2005) 2.81
Single photon-emission computed tomography. J Nucl Cardiol (2010) 2.57
Major depression, physical illness, and suicidal ideation in primary care. Psychosom Med (2003) 2.53
Validity/reliability of PHQ-9 and PHQ-2 depression scales among adults living with HIV/AIDS in western Kenya. J Gen Intern Med (2008) 2.45
Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS. Urology (2012) 2.36
A comparison of clinically important differences in health-related quality of life for patients with chronic lung disease, asthma, or heart disease. Health Serv Res (2005) 2.35
HIV prevention: male circumcision comparison between a nonsurgical device to a surgical technique in resource-limited settings: a prospective, randomized, nonmasked trial. J Acquir Immune Defic Syndr (2012) 2.34
Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol (2010) 2.30
Does this patient have medical decision-making capacity? JAMA (2011) 2.27
Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder. Eur Urol (2012) 2.26
Carotid bruits as a prognostic indicator of cardiovascular death and myocardial infarction: a meta-analysis. Lancet (2008) 2.25
Meta-analysis: the effect of statins on albuminuria. Ann Intern Med (2006) 2.19
One-arm, open-label, prospective, cohort field study to assess the safety and efficacy of the PrePex device for scale-up of nonsurgical circumcision when performed by nurses in resource-limited settings for HIV prevention. J Acquir Immune Defic Syndr (2013) 2.18
Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. Gen Hosp Psychiatry (2008) 2.18
Performance of the PHQ-9 as a screening tool for depression after stroke. Stroke (2005) 2.18
Effectiveness of a 1-year resident training program in clinical research: a controlled before-and-after study. J Gen Intern Med (2007) 2.16
Proteome scale characterization of human S-acylated proteins in lipid raft-enriched and non-raft membranes. Mol Cell Proteomics (2009) 2.16
Impact of pain on depression treatment response in primary care. Psychosom Med (2004) 2.14
Deriving competencies for mentors of clinical and translational scholars. Clin Transl Sci (2012) 2.12
Cholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells. Cancer Res (2002) 2.11
Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. Cancer Res (2009) 2.07
Current role for combination therapy in male LUTS. Arch Esp Urol (2010) 2.03
The Mentoring Competency Assessment: validation of a new instrument to evaluate skills of research mentors. Acad Med (2013) 2.02
Noninvasive methods to evaluate bladder obstruction in men. Int Braz J Urol (2013) 1.98
Ontario multidetector computed tomographic coronary angiography study: field evaluation of diagnostic accuracy. Arch Intern Med (2011) 1.97
Systematic review and metaanalysis: urinary antigen tests for Legionellosis. Chest (2009) 1.89
Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors. PLoS One (2012) 1.89
An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation. Cell Cycle (2009) 1.88
Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients. Psychosom Med (2008) 1.88
How valid are family proxy assessments of stroke patients' health-related quality of life? Stroke (2006) 1.86
Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatol (2005) 1.79
Depression and anxiety in the United States: findings from the 2006 Behavioral Risk Factor Surveillance System. Psychiatr Serv (2008) 1.77
Do the cholesterol-lowering properties of statins affect cancer risk? Trends Endocrinol Metab (2008) 1.74
The effect of antidepressant treatment on chronic back pain: a meta-analysis. Arch Intern Med (2002) 1.74
Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol (2005) 1.72
Clinically important changes in health-related quality of life for patients with chronic obstructive pulmonary disease: an expert consensus panel report. J Gen Intern Med (2003) 1.70
Clinically important differences in health-related quality of life for patients with asthma: an expert consensus panel report. Ann Allergy Asthma Immunol (2003) 1.70
Metronidazole-induced central nervous system toxicity: a systematic review. Clin Neuropharmacol (2011) 1.69
The pro-apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1. EMBO J (2007) 1.69
Systematic review of combination drug therapy for non-neurogenic male lower urinary tract symptoms. Eur Urol (2013) 1.65
Signaling through PI3K/Akt mediates stretch and PDGF-BB-dependent DNA synthesis in bladder smooth muscle cells. J Urol (2003) 1.65
Do somatic and cognitive symptoms of traumatic brain injury confound depression screening? Arch Phys Med Rehabil (2011) 1.64
Association of nocturia and mortality: results from the Third National Health and Nutrition Examination Survey. J Urol (2010) 1.63
Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference. J Gen Intern Med (2009) 1.62
Short-term psychodynamic psychotherapy for somatic disorders. Systematic review and meta-analysis of clinical trials. Psychother Psychosom (2009) 1.62
Lower urinary tract symptoms revisited: a broader clinical perspective. Eur Urol (2008) 1.62
Predicting reports of unmet expectations among rheumatology patients. Arthritis Rheum (2004) 1.61
Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease. Am J Pathol (2012) 1.60
Factors associated with drug adherence and blood pressure control in patients with hypertension. Pharmacotherapy (2006) 1.59
The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer. Cell Cycle (2012) 1.56
Marked disturbance of calcium homeostasis in mice with targeted disruption of the Trpv6 calcium channel gene. J Bone Miner Res (2007) 1.56
Transurethral microwave thermotherapy for benign prostate hyperplasia: separating truth from marketing hype. J Urol (2004) 1.50
High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology (2004) 1.50
Association of urological symptoms and chronic illness in men and women: contributions of symptom severity and duration--results from the BACH Survey. J Urol (2008) 1.49
Lack of impact on polyp detection by fellow involvement during colonoscopy: a meta-analysis. Dig Dis Sci (2013) 1.49
Concordance of near infrared spectroscopy with pressure flow studies in men with lower urinary tract symptoms. J Urol (2010) 1.48
Association between alcohol consumption and both osteoporotic fracture and bone density. Am J Med (2008) 1.46
Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial. JAMA (2011) 1.46
Cholesterol sensitivity of endogenous and myristoylated Akt. Cancer Res (2007) 1.45
Evaluation of acute knee pain in primary care. Ann Intern Med (2003) 1.45
Dexamethasone for acute asthma exacerbations in children: a meta-analysis. Pediatrics (2014) 1.44
The role of cholesterol in prostate cancer. Curr Opin Clin Nutr Metab Care (2006) 1.43
Development and Validation of the Somatic Symptom Disorder-B Criteria Scale (SSD-12). Psychosom Med (2016) 1.42
A three-component model for reengineering systems for the treatment of depression in primary care. Psychosomatics (2002) 1.42
Cancer-related fatigue and its associations with depression and anxiety: a systematic review. Psychosomatics (2009) 1.40
Faculty development seminars based on the one-minute preceptor improve feedback in the ambulatory setting. J Gen Intern Med (2002) 1.40
Pharmacologic treatment of pediatric headaches: a meta-analysis. JAMA Pediatr (2013) 1.39
Pharmacologic management of painful bladder syndrome/interstitial cystitis: a systematic review. Arch Intern Med (2007) 1.38
Re: Constitutional, organopathic and combined homeopathic treatment of benign prostatic hypertrophy: a clinical trial. J Urol (2013) 1.37
Re: LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia. J Urol (2012) 1.37
Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a meta-analysis. Clin Infect Dis (2002) 1.35
Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trial. Control Clin Trials (2003) 1.33
Post-transcriptional regulation of the androgen receptor by Mammalian target of rapamycin. Cancer Res (2005) 1.31
Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network. Menopause (2014) 1.31